"The Best Mix Of Hard-Hitting REAL News & Cutting-Edge Alternative News On The Web"
December 21, 2023
The 'World Health Organization' And Bill Gates Think They Can Fool 'The People' Into Just 'Eating' Their Vaccines Like Food, So They Can Continue Their 'Depopulation Agenda' Unabated
- Globalists Investing 10's Of Millions Creating New Bioweapons For 'Disease X'
Funding from the Bill & Melinda Gates Foundation has helped the Coalition for Epidemic Preparedness Innovations (CEPI) to invest $1.2 million in a startup with Jurata Thin Film Inc. to create under-the-tongue vaccine wafers for needle-free vaccines. CEPI’s mission is to fund the development of “rapid response platforms to develop vaccines against ‘Disease X’".
This is Disease X
What is Disease X?
According to the World Health Organization (WHO) there is a short list of “priority diseases” that could “cause the next deadly pandemic.” We are familiar with the names of most of these diseases — Ebola, SARS and Zika, but the most recent addition to the list is named “Disease X.”
The term Disease X is used by the WHO as “a placeholder” name to describe a disease that is as yet, unknown to medical science as a cause of human infections, and as of yet they do not even know whether they will introduce it as a virus, a bacterium, a fungus or other agent.
The WHO have been trying to alert us to an “UNKNOWN and surprise disease outbreak” which they say “could spread across the world in as little as 36 hours, killing upwards of 80 million people”The Expressreported in September 2019. “And we are not prepared, new research has shockingly claimed.”
(ANP Emergency Fundraiser:If you like stories like these, PLEASE donate to ANP! Due to the globalists war upon truth and the independent media, our monthly revenue has been cut by more than 80% so we need your help more now than ever before. If you are a pro-Liberty, pro-America individual or company willing to sponsor us, we'd be more than happy to arrange something to highlight your company to ANP readers on our website if you can help us keep ANP online. You can donate here or reach us at [email protected] or [email protected] to discuss what kind of ads you might like to run on ANP. Otherwise, anything at all ANP readers can do to help us is hugely appreciated. We thank you! )
Some public health experts believe“the next Disease X will be zoonotic, meaning it will originate in wild or domestic animals, then spill over to infect humans. Ebola, HIV/AIDS and COVID-19 were zoonotic outbreaks. However, there are other sources of diseases and bioterrorism could be the cause of the next pandemic.”
“The possibility of an engineered pandemic pathogen also cannot be ignored,” said the authors of a 2021 article in the journal Infection Control & Hospital Epidemiology. “The release of such pathogens, either through laboratory accidents or as an act of bioterrorism, might lead to a disastrous Disease X as well and has been remarked as a global catastrophic risk,” the authors added.
Choices choices!…. whatever they decide it is, we are clearly meant to be afraid already, as it “isn’t the stuff of science fiction,” according to Dr. Richard Hatchett, of the CEPI, who told the Telegraph, “This is a scenario we have to prepare for.” – “This is Disease X.” he said,
Hatchett of CEPI was the one to name whatever it will be, “Disease X.” back in 2018, and has prepared a vaccine for it, with the financial help from the Bill and Melinda Gates Foundation. Which was fortunate as “It is not an exaggeration to say that there is potential of a Disease X event just around the corner,” according to Dr. Pranab Chatterjee, researcher at the Department of International Health at Johns Hopkins Bloomberg School of Public Healthtold the National Post.
Gates Funding
Back in January 2022 the Coalition for Epidemic Preparedness Innovations (CEPI)announced that the Bill & Melinda Gates Foundation and Wellcome pledged $300 million to them to fight COVID-19 and combat threat of future pandemics. According to CEPI the new funding commitments would support their goal to “condense new vaccine development timelines to 100 days, a third of the time it took to develop a COVID-19 vaccine.”Source
Now “the Coalition for Epidemic Preparedness Innovations is investing $1.2 million in a startup to create under-the-tongue vaccine wafers that can be stored at any temperature. Critics question the reliability of the technology and the safety of the mRNA platform”writes Brenda Baletti, Ph.D. for the Children’s Health Defense, in her article that we have republished a portion of below.
Prepping for ‘Disease X’: Gates-Backed Group Funds Needle-Free mRNA Vaccine ‘Wafer’ Technology.
The partnership will begin with a $1.2 million investment to help Jurata develop its proprietary vaccine platform, which the company says stabilizes mRNA-containing lipid nanoparticle vaccine technologies in a thin film.
Jurataclaims the film is designed to be “thermostable,” produced and stored at room temperature and remain stable for three years, eliminating the need for energy-intensive cold storage required by current mRNA vaccines.
The film can be placed inside the cheek or under the tongue to deliver the vaccine. It can also be rehydrated with an aqueous solution and taken nasally or through other means that don’t require passage through the digestive tract.
Jurata and CEPI tout the technology as key to getting vaccines to poor people across the world. “If shown to be successful,”CEPI said in its press release, the technology will “help expand access to mRNA vaccines in underserved regions and advance the global response to future emerging infectious disease outbreaks.”
However, scientists who spoke to The Defender said that “success” seemed unlikely anytime soon. They also said the technology could pose problems even beyond the serious known risks with existing mRNA transfection technology.
Brian Hooker, Ph.D., senior director of science and research at Children’s Health Defense (CHD), said:
“Vaccines require cold storage (mostly refrigeration) and mRNA vaccines are especially susceptible to heat damage during shipping and storage. A thermostable platform completely eliminates the need for refrigeration and would be a huge breakthrough in getting rid of ‘cold chain requirements’ in delivering vaccines to the developing world and would also constitute a big cost savings in deployment overall.
“But outside of the other obvious issues with mRNA vaccines, I would be worried that the mRNA wouldn’t be as thermostable as purported and this would induce sequence mutations and other damage to the genetic code.”
Jurata is a small biotech firm developing the films for vaccine delivery and other therapeutics. Its founders also founded Bamboo Therapeutics, a gene therapy biotech company acquired in 2016 by Pfizerin a deal valued at $827 million.
THERMOSTABLE, NEEDLE-FREE VACCINES ARE A ‘RED HERRING’
Jurata is the fifth partner announced as part of CEPI’s January 2022 call for proposals for thermostable vaccine manufacturing innovations. The company said more announcements are on the horizon.
They claim these technologies have the potential to make vaccines accessible to remote areas, particularly in the Global South, where infrastructure for the cold storage necessary for vaccines is lacking, especially for mRNA vaccines which require ultra-cold temperatures of -20 degrees Celsius to -80 C.
They also say these technologies can “help promote vaccine uptake in areas of vaccine hesitancy” and reduce the need for providers by making it possible for people to self-administer vaccines.
Under the terms of the agreement with CEPI, Jurata committed to ensuring vaccine supply for the Global South by producing a volume of vaccines “required to meet public health needs,” setting affordable prices for Global South countries and potentially transferring the technology to Global South manufacturers.
Thermostable needle-free technologies are being widely promoted even though few clinical trials on any of these technologies have been completed and no such vaccine has yet been approved by regulators.
CHD Staff Scientist J. Jay Couey, Ph.D., told The Defender he thought the hype around such technologies is a “red herring” meant to make the public think any problems with these vaccines are technical questions of storage or delivery method — rather than the much more serious threat posed by mRNA transfection technologies themselves.
Despite all the boosterism around new vaccine delivery methods, the first-ever clinical trial of vaccine patches in children for the measles-rubella vaccine tested in Gambia was only shared in May by Micron Biomedical during the Microneedles 2023 conference in Seattle.
The Phase 1/2 trial delivered “promising” results, although to date the trial results have not been published in a peer-reviewed publication.
Despite the limited research, the Gates Foundation in November gave Micron Biomedical $23.6 million to fund the first mass production of needle-free vaccine technology. The Centers for Disease Control and Prevention also partnered with Micron.
CEPI says it hopes to use its funding to drive the development of such vaccines.
“We’re really looking to see a step change in the way that some of these vaccines can be stored and delivered,” said Ingrid Kromann, CEPI’s acting director of Vaccine Manufacturing and Supply Chain in a press release on the funding opportunity.
Of the $17.5 million CEPI is dedicating to thermostable vaccine development, it has already awarded $2 million to Tiba Biotech for its RNA nanoparticle delivery platform and $4.3 million to Vaxxas for pre-clinical trials on a microarray patch, $3.6 million to Gennova Biopharmaceuticals for a self-amplifying mRNA platform and $1.6 million to AvaxziPen — a needle-free platform to deliver solid-dose vaccine formulations via a pen applicator.
In the case of Jurata’s microfilm, the CEPI funding will support pre-clinical trials.
Given that mRNA technology became “one of the technological ‘shining stars’ during the COVID-19 pandemic,”Kromman said, thermostable vaccines with easy delivery like Jurata’s will be key to “advancing CEPI’s pandemic preparedness plan to accelerate the speed and scale of our response to future epidemics and pandemics, and heighten access to vaccine doses.” You can read this entire story here.
ANP is a participant in the Amazon Services LLC Associates Program.
ANP EMERGENCY Fundraiser: ‘Dangerous, Derogatory, Harmful, Unreliable!’Those are some of the exact words used by Google’s censors, aka 'Orwellian content police,' in describing many of our controversial stories. Stories later proven to be truthful and light years ahead of the mainstream media. But because we reported those 'inconvenient truths' they're still trying to hide, they pulled their ads from ANP.
Checks or money orders made payable to Stefan Stanford or Susan Duclos can be sent to:
P.O. Box 575
McHenry, MD. 21541
Anything at all at Amazon purchased through this ANP link will allow ANP to make a bit of revenue, all of which will be used to keep ANP online and to keep a roof over our heads.
